MetLife Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.67M	Buy	100,456 +635	+0.6%	+$37K	0.03%	567
2025 Q4	$5.93M	Sell	99,821 -4,644	-4%	-$253K	0.03%	551
2025 Q3	$5.66M	Sell	104,465 -4,696	-4%	-$269K	0.03%	586
2025 Q2	$6M	Buy	109,161 +2,935	+3%	+$173K	0.04%	507
2025 Q1	$7.51M	Sell	106,226 -1,177	-1%	-$79.2K	0.04%	434
2024 Q4	$7.06M	Buy	107,403 +9,031	+9%	+$605K	0.04%	389
2024 Q3	$6.91M	Sell	98,372 -1,597	-2%	-$133K	0.04%	373
2024 Q2	$8.23M	Buy	99,969 +95,406	+2,091%	+$7.94M	0.05%	289
2024 Q1	$399K	Buy	4,563 +12	+0.3%	+$1.07K	﹤0.01%	1802
2023 Q4	$439K	Sell	4,551 -80	-2%	-$7.08K	﹤0.01%	1769
2023 Q3	$410K	Buy	4,631 +6	+0.1%	+$534	﹤0.01%	1756
2023 Q2	$401K	Buy	4,625 +803	+21%	+$75.6K	﹤0.01%	1847
2023 Q1	$372K	Buy	3,822 +8	+0.2%	+$829	﹤0.01%	1834
2022 Q4	$395K	Buy	3,814 +18	+0.5%	+$1.69K	﹤0.01%	1795
2022 Q3	$322K	Sell	3,796 -92	-2%	-$8.19K	﹤0.01%	1957
2022 Q2	$322K	Buy	3,888 +241	+7%	+$19.2K	﹤0.01%	1973
2022 Q1	$281K	Buy	+3,647	New	+$305K	﹤0.01%	2132
2019 Q2	–	Sell	-242	Closed	-$21.5K	–	2450
2019 Q1	$21.5K	Buy	242 +1	+0.4%	+$93	﹤0.01%	2339
2018 Q4	$20.5K	Sell	241 -2	-0.8%	-$190	﹤0.01%	2339
2018 Q3	$23.6K	Buy	+243	New	+$24.3K	﹤0.01%	2374